Biotech sovereignty: Canada’s next strategic imperative
The country excels at generating research and patents, but too often falls short in commercialization, scale-up, and retaining ownership of intellectual property.
The current geopolitical and economic environment presents both significant challenges and opportunities for Canada’s biotech sector. Global supply chain disruptions, shifting international alliances, and growing emphasis on domestic innovation have reinforced the need for...
SPONSORED CONTENT
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
